Pharma Journalist -

Veloxis Pharmaceuticals asserted that it has submitted a supplemental New Drug Application to the U.S Food and Drug Administration seeking new indication for ENVARSUS XR (tacrolimus…
Read More...

Ligand Pharmaceuticals signed a license agreement extending Roivant sciences exclusive global rights to develop and commercialize LGD-6972, ligand's glucagon receptor antagonist. As…
Read More...

Biohaven Pharmaceuticals asserted that it has enrolled the first patient in a Phase 3 Clinical Trial of Zydis that is a orally dissolving tablet formulation of rimegepant for the…
Read More...

Apexigen which is clinical-stage bio pharmaceutical company and the Pediatric Brain Tumor Consortium (PBTC) announced a Clinical trial collaboration to assess and evaluate Apexigen's …
Read More...

Citius Pharmaceuticals which is a specialty pharmaceutical company announced that the Company is finalizing a higher potency corticosteroid in its steroid/anesthetic topical formulation…
Read More...

SMi is delighted to announce its 2nd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 21st - 22nd May 2018. There is a £100 saving when booking…
Read More...

Forendo Pharma which is a drug development company developing novel oral treatments for endometriosis patients asserted the appointment of David Colpman as a Non-executive Director to…
Read More...

Building on the success of SMi's 10th Annual Flagship Conference Pre-Filled Syringes, SMi are thrilled to present the launch of their Injectable Drug Delivery conference being held at…
Read More...

23andMe which is the leading personal genetics company received FDA Authorization for a direct-to-consumer genetic test for cancer risk.The authorization allows 23andMe to provide…
Read More...

Theratechnologies and its partner TaiMed Biologics, Inc. (TaiMed) asserted that the U.S. Food and Drug Administration (FDA) has granted approval of Trogarzo (ibalizumab-uiyk) Injection.…
Read More...